Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan

Post time 2022-7-2 07:56:21

journal：Value in Health Regional Issues

Authors：Garth W. Strohbehn; Jennifer H. Cooperrider; Dali Yang; A. Mark Fendrick; Mark J. Ratain; Gregory S. Zaric

Published date：2022-9-

DOI：10.1016/j.vhri.2022.01.007

Article link：http://dx.doi.org/10.1016/j.vhri.2022.01.007

Article Source：Elsevier BV。

Remark：

Post time 2022-7-2 07:56:22

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-7-2 09:18:34

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today